Alessia Balestrini

Alessia Balestrini

Auto-generated profile, based on publicly available information

Alessia Balestrini

Department of Immunology Discovery, Genentech, Inc., South San Francisco, CA 1

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAlessia Balestrini
Alessia Balestrini
VJVictory Joseph
Victory Joseph
MDMichelle Dourado
Michelle Dourado
RRRebecca M. Reese
Rebecca M. Reese
SSShannon D. Shields
Shannon D. Shields
LRLorena Riol-Blanco
Lorena Riol-Blanco
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1 is involved in the induction of airway inflammation and hyperreactivity. Here, the discovery and early clinical development of GDC-0334, a highly potent, selective, and orally bioavailable TRPA1 antagonist, is described. GDC-0334 inhibited TRPA1 function on airway smooth muscle and sensory neurons, decreasing edema, dermal blood flow (DBF), cough, and allergic airway inflammation in several preclinical species. In a healthy volunteer Phase 1 study, treatment with GDC-0334 reduced TRPA1 agonist-induced DBF, pain, and itch, demonstrating GDC-0334 target engagement in humans. These data provide therapeutic rationale for evaluating TRPA1 inhibition as a clinical therapy for asthma.

3 April 2023
Verified
Other
Open access
ABAlessia Balestrini
Alessia Balestrini
LNLaura Nicolas
Laura Nicolas
KYKatherine Yang-Lott
Katherine Yang-Lott
OGOlga Guryanova
Olga Guryanova
RLRoss L. Levine
Ross L. Levine
JPJohn H.J. Petrini
John H.J. Petrini

3 April 2023
Verified
Other
Open access
ABAlessia Balestrini
Alessia Balestrini
LNLaura Nicolas
Laura Nicolas
KYKatherine Yang-Lott
Katherine Yang-Lott
OGOlga Guryanova
Olga Guryanova
RLRoss L. Levine
Ross L. Levine
JPJohn H.J. Petrini
John H.J. Petrini

3 April 2023
Verified
Other
Open access
ABAlessia Balestrini
Alessia Balestrini
LNLaura Nicolas
Laura Nicolas
KYKatherine Yang-Lott
Katherine Yang-Lott
OGOlga Guryanova
Olga Guryanova
RLRoss L. Levine
Ross L. Levine
JPJohn H.J. Petrini
John H.J. Petrini

3 April 2023
Verified
Other
Open access
ABAlessia Balestrini
Alessia Balestrini
LNLaura Nicolas
Laura Nicolas
KYKatherine Yang-Lott
Katherine Yang-Lott
OGOlga Guryanova
Olga Guryanova
RLRoss L. Levine
Ross L. Levine
JPJohn H.J. Petrini
John H.J. Petrini

3 April 2023
Verified
Other
Open access
ABAlessia Balestrini
Alessia Balestrini
LNLaura Nicolas
Laura Nicolas
KYKatherine Yang-Lott
Katherine Yang-Lott
OGOlga Guryanova
Olga Guryanova
RLRoss L. Levine
Ross L. Levine
JPJohn H.J. Petrini
John H.J. Petrini